5T4Z image
Entry Detail
PDB ID:
5T4Z
Keywords:
Title:
STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2016-08-30
Release Date:
2017-03-08
Method Details:
Experimental Method:
Resolution:
1.99 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:antibody DH501 Fab heavy chain
Chain IDs:A (auth: H), C (auth: A)
Chain Length:230
Number of Molecules:2
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Description:antibody DH501 Fab light chain
Chain IDs:B (auth: L), D (auth: B)
Chain Length:216
Number of Molecules:2
Biological Source:Macaca mulatta
Ligand Molecules
Primary Citation

Abstact

Induction of broadly neutralizing antibodies (bnAbs) that target HIV-1 envelope (Env) is a goal of HIV-1 vaccine development. A bnAb target is the Env third variable loop (V3)-glycan site. To determine whether immunization could induce antibodies to the V3-glycan bnAb binding site, we repetitively immunized macaques over a 4-year period with an Env expressing V3-high mannose glycans. Env immunizations elicited plasma antibodies that neutralized HIV-1 expressing only high-mannose glycans-a characteristic shared by early bnAb B cell lineage members. A rhesus recombinant monoclonal antibody from a vaccinated macaque bound to the V3-glycan site at the same amino acids as broadly neutralizing antibodies. A structure of the antibody bound to glycan revealed that the three variable heavy-chain complementarity-determining regions formed a cavity into which glycan could insert and neutralized multiple HIV-1 isolates with high-mannose glycans. Thus, HIV-1 Env vaccination induced mannose-dependent antibodies with characteristics of V3-glycan bnAb precursors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures